These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 34931228)
1. Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis. Stafford MYC; Willoughby CE; Walsh CP; McKenna DJ Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34931228 [TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of osteopontin expression in patients with prostate cancer: a systematic review and meta-analysis. Yu A; Guo K; Qin Q; Xing C; Zu X Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 33635319 [TBL] [Abstract][Full Text] [Related]
3. The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis. Wu XL; Zhang JW; Li BS; Peng SS; Yuan YQ Medicine (Baltimore); 2017 Dec; 96(51):e9279. PubMed ID: 29390487 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer. Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409 [TBL] [Abstract][Full Text] [Related]
5. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis. Yuan Y; Xu XY; Zheng HG; Hua BJ Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605 [TBL] [Abstract][Full Text] [Related]
6. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies. Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Expression of MicroRNAs in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Zhan B; Lu D; Luo P; Wang B Clin Lab; 2016 Nov; 62(11):2203-2211. PubMed ID: 28164670 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer. Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer. Liu JB; Yan YJ; Shi J; Wu YB; Li YF; Dai LF; Ma XT Medicine (Baltimore); 2019 Jul; 98(29):e16193. PubMed ID: 31335671 [TBL] [Abstract][Full Text] [Related]
10. MiR-24-3p as a prognostic indicator for multiple cancers: from a meta-analysis view. Wang H; Chen C; Ding K; Zhang W; Hou J Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33206184 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis. Pan F; Mao H; Deng L; Li G; Geng P Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microRNA-145 in patients with various cancers: a meta-analysis. Dai SL; Zhou J; Pan C; Huang G; Shi ZL; Yang SY; Yang KX Cancer Biomark; 2015; 15(4):507-13. PubMed ID: 25792469 [TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of MicroRNA-153 in human cancers: A meta-analysis. Huang M; Li C; Kong F; Wu Y; Yuan Q; Hu L Medicine (Baltimore); 2020 Nov; 99(46):e22833. PubMed ID: 33181653 [TBL] [Abstract][Full Text] [Related]
15. Role of MicroRNA-124 as a Prognostic Factor in Multiple Neoplasms: A Meta-Analysis. Zhou Z; Lv J; Wang J; Yu H; Lu H; Yuan B; Han J; Zhou R; Zhang X; Yang X; Yang H; Lu Q; Li P Dis Markers; 2019; 2019():1654780. PubMed ID: 31885731 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis. Chao C; Sang C; Wang M; Wang Z; Li Y; Luo G; Zhang X Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803920 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis. Li ML; Luo HY; Quan ZW; Huang LT; Wang JH Int J Biol Markers; 2023 Mar; 38(1):3-14. PubMed ID: 36604990 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis. Chen YL; Liu XL; Li L BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data. Rana S; Valbuena GN; Curry E; Bevan CL; Keun HC Br J Cancer; 2022 Feb; 126(3):502-513. PubMed ID: 35022525 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of MicroRNA-196a in Asian Cancer Patients: a Meta-Analysis. Cai X; Liu X; Lu N; Xiao M; Li Z Clin Lab; 2016 Nov; 62(11):2257-2265. PubMed ID: 28164681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]